Fexlamose
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Fexlamose, covering 2024-12-13 to 2024-12-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD [Phase 2]